Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

NCT07441395 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis
Atopic Dermatitis Eczema
Eczema
Eczema, Atopic

Interventions

DRUG: Soquelitinib
DRUG: Placebo

Sponsor

Corvus Pharmaceuticals, Inc.